BNP Paribas Asset Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Sell |
1,395,726
-232,293
| -14% | -$1.89M | 0.03% | 433 |
|
|
2025
Q1 | $12.8M | Buy |
1,628,019
+106,235
| +7% | +$834K | 0.03% | 407 |
|
|
2024
Q4 | $22.7M | Buy |
1,521,784
+590,736
| +63% | +$8.8M | 0.06% | 310 |
|
|
2024
Q3 | $14.2M | Buy |
931,048
+186,750
| +25% | +$2.86M | 0.04% | 374 |
|
|
2024
Q2 | $11.3M | Buy |
744,298
+59,273
| +9% | +$903K | 0.03% | 404 |
|
|
2024
Q1 | $12.9M | Buy |
685,025
+145,298
| +27% | +$2.74M | 0.03% | 390 |
|
|
2023
Q4 | $10.3M | Buy |
539,727
+22,863
| +4% | +$437K | 0.03% | 417 |
|
|
2023
Q3 | $9.28M | Sell |
516,864
-94,308
| -15% | -$1.69M | 0.03% | 419 |
|
|
2023
Q2 | $12.4M | Sell |
611,172
-163,620
| -21% | -$3.32M | 0.04% | 364 |
|
|
2023
Q1 | $14.1M | Buy |
774,792
+9,242
| +1% | +$169K | 0.05% | 362 |
|
|
2022
Q4 | $15.8M | Buy |
765,550
+142,986
| +23% | +$2.96M | 0.06% | 348 |
|
|
2022
Q3 | $16.3M | Buy |
622,564
+63,962
| +11% | +$1.67M | 0.06% | 323 |
|
|
2022
Q2 | $14.2M | Sell |
558,602
-238,489
| -30% | -$6.04M | 0.05% | 341 |
|
|
2022
Q1 | $25.2M | Sell |
797,091
-64,203
| -7% | -$2.03M | 0.09% | 267 |
|
|
2021
Q4 | $34.9M | Buy |
861,294
+76,188
| +10% | +$3.08M | 0.12% | 211 |
|
|
2021
Q3 | $27.4M | Buy |
785,106
+473,310
| +152% | +$16.5M | 0.1% | 234 |
|
|
2021
Q2 | $8.56M | Buy |
+311,796
| New | +$8.56M | 0.03% | 460 |
|